Clinical Trials Logo

Clinical Trial Summary

Evaluation of the effect of URELL consumption on the occurrence of recurrent urinary tract infection (Acute cystitis, pyelonephritis and asymptomatic bacteriuria).


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Masking: Double Blind (Subject, Investigator)


Related Conditions & MeSH terms


NCT number NCT01818180
Study type Interventional
Source Hopital Foch
Contact
Status Terminated
Phase N/A
Start date May 2010

See also
  Status Clinical Trial Phase
Recruiting NCT04095572 - Alternative Prophylaxis in Female Recurrent Urinary Tract Infections Phase 4
Active, not recruiting NCT03697096 - The INSPIRE-ASP UTI Trial N/A
Recruiting NCT02829060 - Endourology Disease Group Excellence (EDGE) Consortium: Antibiotics (Abx) for Percutaneous Nephrolithotomy (PCNL) Part 2 N/A
Completed NCT02728089 - Study of Ceftolozane/Tazobactam (MK-7625A) in Japanese Participants With Uncomplicated Pyelonephritis and Complicated Urinary Tract Infection (MK-7625A-014) Phase 3